腹腔镜下头尾侧联合入路治疗右半结肠癌的疗效分析

鲍新民, 王日玮, 张开华, 刘奇盛, 万焱华, 廖强明 - 肿瘤防治研究, 2020 - zlfzyj.com
摘要目的探讨头尾侧联合入路在腹腔镜右半结肠癌切除术中的近期临床效果. 方法收集60
例右半结肠癌患者临床资料, 分为观察组(头尾侧联合入路) 和对照组(中间入路) …

[HTML][HTML] Delineating the underlying molecular mechanisms and key genes involved in metastasis of colorectal cancer via bioinformatics analysis

C Qi, Y Chen, Y Zhou, X Huang, G Li… - Oncology …, 2018 - spandidos-publications.com
Colorectal cancer (CRC) is considered the world's fourth most deadly cancer. Its metastasis
is associated with poor prognosis and weakens the effects of treatment. However, the …

Nuclear-localized costimulatory molecule 4-1BBL promotes colon cancer cell proliferation and migration by regulating nuclear Gsk3β, and is linked to the poor …

Y Ge, W Chen, X Zhang, H Wang, J Cui, Y Liu, S Ju… - Cell Cycle, 2020 - Taylor & Francis
Anti-tumor immune response and the prognosis of tumor are the results of competition
between stimulatory and inhibitory checkpoints. Except for upregulating inhibitory …

Clinical Significance and Prognostic Value of miR‐28‐5p in Colon Cancer

J Li, K Li, M Xie, Y Tang, Y Tang, B Hu - Disease Markers, 2020 - Wiley Online Library
Background. The association of miR‐28‐5p with colon cancer remains to be elucidated. This
study aimed to determine the clinical significance and prognostic value of miR‐28‐5p in …

[HTML][HTML] Isoliquiritigenin inhibits colorectal cancer cells HCT-116 growth by suppressing the PI3K/AKT pathway

YL Huang, F Wei, K Zhao, Y Zhang, D Wang… - Open life sciences, 2017 - degruyter.com
Isoliquiritigenin (ISL), a member of the flavonoids, is known to possess antitumor activity in
different types of cancer including human breast cancer, hepatoma cancer, prostate cancer …

Development of Novel Cancer Biomarkers for Diagnosis and Prognosis

KA Janjua, R Shahzad, A Shehzad - Cancer Biomarkers in Diagnosis and …, 2022 - Springer
In the past few decades, extensive research has been carried out to find novel biomarkers
for various cancers. Cancer biomarkers play an important role in the screening, diagnosis …

Screening results of colorectal cancer in the Almaty region of the Republic of Kazakhstan-features and modifying factors of efficiency.

RS Zholmurzaeva, DA Ospanova, LA Pak… - 2021 - cabidigitallibrary.org
Introduction: Screening of risk factors and early stages of malignancy is currently one of the
key areas in oncology. Neoplasms of colorectal localization are among the priorities for …

Early detection of colorectal cancer: preliminary report on the prospective value of a combined screening method for occult rectal bleeding

S Ottó, JH Czalbert, I Papp, S Eckhardt - Oncology, 1990 - karger.com
The authors have developed a specific, sensitive, simple and economic method for the
detection of occult colorectal bleeding. The new technique consists of the traditional guaiac …

Resource allocation models in healthcare decision making

A Hiassat - 2017 - uwspace.uwaterloo.ca
We present models for allocating limited healthcare resources efficiently among target
populations in order to maximize society's welfare and/or minimize the expected costs. In …

Técnicas de diagnóstico para detección de sangre oculta en heces como biomarcador de cáncer colorrectal

LXR López, ÁLM Diaz, LML Solano… - Ciencia y Salud …, 2020 - dialnet.unirioja.es
Introducción. El test de sangre oculta en heces, es una prueba que identifica mínimas
cantidades de hemoglobina en materia fecal que pueden tener origen en cualquier parte …